Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Cipla, Pfizer and DRL among  66 drug firms that fail quality test

      Cipla, Pfizer and DRL among 66 drug firms that fail quality test

      Ruby Khatun Khatun23 July 2017 9:52 AM IST
      Some of Major drug companies like Pfizer, Alembic Pharma, Cipla, Dr Reddy’s Laboratories & Zydus Healthcare are among 66 drug companies that have...
      Spanish biotech Oryzon slumps as Roche ditches cancer drug

      Spanish biotech Oryzon slumps as Roche ditches cancer drug

      Ruby Khatun Khatun23 July 2017 9:51 AM IST
      Shares in Spanish biotech company Oryzon Genomics plunged 30 percent on Thursday after Swiss drugmaker Roche pulled out of a deal to develop its...
      Alembic Pharmaceuticals Q1FY18 consolidated net profit declines 39 per cent yoy

      Alembic Pharmaceuticals Q1FY18 consolidated net profit declines 39 per cent yoy

      Ruby Khatun Khatun23 July 2017 9:50 AM IST
      Alembic Pharmaceuticals consolidated revenue for the quarter came in at Rs. 648 crore, registering 12% yoy decline.This was driven by 21% yoy decrease...
      Sanofi Indias board declares an interim dividend of Rs 18

      Sanofi India's board declares an interim dividend of Rs 18

      Ruby Khatun Khatun23 July 2017 9:49 AM IST
      The Board of Directors of the Sanofi India at its Meeting held on Wednesday has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each...
      USFDA completed audit of Mexican plant: Dr Reddy

      USFDA completed audit of Mexican plant: Dr Reddy's Laboratories

      Ruby Khatun Khatun23 July 2017 9:49 AM IST
      New Delhi: Drug major Dr Reddy's Laboratories on Friday said the US health regulator has completed audit of its API Cuernavaca Plant in Mexico."The...
      Natco Pharma gets EIR from USFDA for Kothur facility

      Natco Pharma gets EIR from USFDA for Kothur facility

      Ruby Khatun Khatun22 July 2017 10:53 AM IST
      New Delhi: Drug firm Natco Pharma on Friday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
      Trump unveils companies 500 million dollar US drug packaging project

      Trump unveils companies 500 million dollar US drug packaging project

      Ruby Khatun Khatun22 July 2017 9:51 AM IST
      WASHINGTON: President Donald Trump on Thursday announced a $500 million investment that Corning Inc is making with pharmaceutical giants Merck and...
      CDSCO sets up a GST Helpdesk

      CDSCO sets up a GST Helpdesk

      Ruby Khatun Khatun22 July 2017 9:49 AM IST
      There has been a lots of confusion among drug companies, distributors, and chemists after implementation of GST on 1st July 2017 regarding pricing of...
      Tata sells Advinus Therapeutics to Eurofins Scientific

      Tata sells Advinus Therapeutics to Eurofins Scientific

      Ruby Khatun Khatun22 July 2017 9:47 AM IST
      The Tata Group and the individual shareholders of Advinus Therapeutics decided to sell the company to Eurofins Scientific for an undisclosed...
      Anti-HCV Rapid Kit Sensitivity criteria reviewed

      Anti-HCV Rapid Kit Sensitivity criteria reviewed

      Ruby Khatun Khatun22 July 2017 9:15 AM IST
      Drugs Controller General (India), Directorate General of Health Services had revised specification /criteria of acceptance for quality test for...
      Valeant to sell Obagi Medical Products business for 190 million dollar

      Valeant to sell Obagi Medical Products business for 190 million dollar

      Ruby Khatun Khatun22 July 2017 9:14 AM IST
      Valeant Pharmaceuticals International Inc, said on Monday it would sell its Obagi Medical Products business for $190 million in cash, as part of the...
      DBT launches Sohum - an innovative newborn hearing screening device

      DBT launches Sohum - an innovative newborn hearing screening device

      Ruby Khatun Khatun22 July 2017 9:00 AM IST
      The Honorable Minister of State, Ministry of Science and Technology & Earth Sciences, Shri Y.S. Chowdary, launched Sohum – the newborn hearing...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok